ClinicalTrials.gg
Status unknownNCT06121687Shaeer-IUpdated Nov 8, 2023

Shaeer's Vein Ligation-I: Internal Pudendal Vein Sub-Gluteal Ligation For Veno Occlusive Erectile Dysfunction

An interventional study of Shaeer-I and PPI in Erectile Dysfunction, sponsored by Kasr El Aini Hospital. Status unknown at 1 site in Egypt. Open to male participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2023-11-08.

Sponsored by Kasr El Aini Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 85 Years
Sex
Male
01

Study summary

The goal of this interventional study is to evaluate a new surgical technique (Shaeer's Sub-Gluteal Internal Pudendal Vein Ligation (SHAEER-I)) in patients with deep system veno-occlusive erectile dysfunction (VOD)

. The main question[s] it aims to answer are:

  • [Will the patients have satisfactory rigidity after surgery]
  • [What will the Satisfaction rates be]
  • [Will there be complications]

Participants will

  • Undergo SHAEER-I or PPI surgery
  • Report the results of surgery for at least 6 months
Read the detailed description

Title Shaeer's Vein Ligation - I: Internal Pudendal Vein Sub-Gluteal Ligation For The Management of Veno Occlusive Erectile Dysfunction. The Surgical Study

Objectives Vein ligation surgery for veno-occlusive erectile dysfunction (VOD) has largely been unsuccessful, possibly due to the extensive collateral circulation, but also due to confinement to intermediate vein system ligation. The deep system of veins has been surgically inaccessible.

This is study evaluates Shaeer's Vein Ligation - I (Shaeer-I): the first surgical technique for ligation of the deep system of veins; the internal pudendal vein.

Methods Surgery shall be performed for patients with VOD who are not responding to medical treatment and are candidate for penile prosthesis implantation. VOD will be documented by cavernosography to affect the deep system of veins; the internal pudendal vein, unilaterally.

Patients will be randomized into two groups: one to proceed to Penile Prosthesis Implantation (PPI Group), and another to be offered a choice between PPI or SHAEER-I. Patients opting for PPI will be assigned to the PPI group. Patients opting to SHAEER-I will be assigned to (SHAEER-I group).

Primary outcome will be measured as per satisfaction rates and erectile function, at the 6th month post-operative. Evaluation shall be through the Treatment Satisfaction Scale (TSS) Scores and the Abbreviated International Index of Erectile Function (IIEF-5). Outcome assessor/s shall be blinded as to the patient group. Secondary outcome will be complications -if any.

Surgical Technique for SHAEER-I:

SHAEER-I targets ligation of the internal pudendal vein at the point where the vein exits the lesser sciatic foramen, courses superficial to the sacrospinous ligament then dips into the greater sciatic foramen, under the gluteus maximus muscle.

Surface anatomical landmarks are used to identify the ischial spine, at the intersection between two lines: a vertical line bridging the posterior superior iliac spine to the ischial tuberosity, and a horizontal one extending from the sacro-coccygeal joint, laterally. The internal pudendal vein emerges and dips lateral to the ischial spine.

A hockey-stick or vertical incision encompassing the target point is cut, lateral to anal cleft. Subcutaneous fat is dissected down to the gluteus maximus, which is split along the direction of its fibers. The internal pudendal vein can be identified and ligated deep to the muscle, coursing between the pudendal nerve medially and the pudendal artery laterally.

Pre-operative Evaluation:

  • Patients will fill the IIEF-5 questionnaire
  • Review of past-utilization of medical treatment for ED (erectile dysfunction)
  • Laboratory Investigations: serum testosterone (free and total), prolactin, blood sugar profile, lipid profile, general pre-operative investigations.
  • Imaging: penile duplex and cavernosography.
02

Conditions studied

  • Erectile Dysfunction

Browse trials for

Keywords

  • veno-occlusive erectile dysfunction
  • erectile dysfunction
  • venous leak
03

In context

Erectile Dysfunction

698 studies on the registry are indexed under Erectile Dysfunction; 116 are open to participants now.

This study's planned enrollment of 60 is below the median of 72 across 552 interventional studies indexed under Erectile Dysfunction.

Browse Erectile Dysfunction studies →

Lead sponsor

Kasr El Aini Hospital is the lead sponsor of 283 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male patients with deep system veno-occlusive erectile dysfunction
  • Lack of response to medical treatment for erectile dysfunction including PDEi (Phosphodiesterase Inhibitors), aphrodisiacs, hormonal therapy (if there is a hormonal disturbance), and intracavernous injections, despite control of risk factors such as diabetes mellitus.

Exclusion criteria

Exclusion Criteria:

  • Patients with uncontrolled diabetes, smokers and patients with anesthesia risk
  • Patients with arteriogenic erectile dysfunction, penile fibrosis, Peyronie's disease or psychiatric disorders.
  • Patients with bilateral deep system VOD
  • Patients who refuse to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Shaeer-I

    Shaeer-I High Vein Ligation surgery will be performed. A hockey-stick or vertical incision encompassing the target point is cut, lateral to anal cleft. Subcutaneous fat is dissected down to the gluteus maximus, which is split along the direction of its fibers. The internal pudendal vein can be identified and ligated deep to the muscle, coursing between the pudendal nerve medially and the pudendal artery laterally.

    Procedure: Shaeer-I

  • Active comparator
    PPI

    Penile prosthesis implantation (PPI) will be performed.

    Procedure: PPI

Interventions

  • ProcedureShaeer-I

    Ligation of the internal pudendal vein under the Gluteus Maximus muscle as it courses above the scar-spinous ligament.

    Also known as: Shaeer's Vein Ligation-I

  • ProcedurePPI

    Penile prosthesis implantation (PPI) will be performed

    Also known as: Penile Prosthesis Implantation

06

What researchers measure

Primary outcomes

  1. Treatment Satisfaction Scale

    A questionnaire to assess satisfaction with the results of surgery

    Time frame: 6 months

  2. International Index of Erectile Function

    A questionnaire to assess erectile function

    Time frame: 6 months

Secondary outcomes

  1. Complications

    Complications - if any - shall be recorded

    Time frame: 6 months

07

Study locations

1 site
  • Kasr El Aini Faculty of Medicine, Cairo University
    Cairo, 12311, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06121687
Responsible party
Osama Shaeer (Prof.Dr., Kasr El Aini Hospital) — Principal investigator
First posted
Nov 8, 2023
Start date
Jan 2024 (estimated)
Primary completion
Jan 2025 (estimated)
Completion
Feb 2025 (estimated)
Last update
Nov 8, 2023

Study contacts

Osama Shaeer, MD, PhD
Contact
osamashaeer@gmail.com
00201006600606
Osama Shaeer, MD, PhD
study chair · kasr El Aini Faculty of Medicine, Cairo University, Egypt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion